These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 11991791
21. Human type 1 estrogen sulfotransferase: catecholestrogen metabolism and potential involvement in cancer promotion. Faucher F, Lacoste L, Luu-The V. Ann N Y Acad Sci; 2002 Jun; 963():221-8. PubMed ID: 12095948 [Abstract] [Full Text] [Related]
22. [The significance of estrogen metabolism for hormone-dependent neoplasms from the clinical-pharmacological viewpoint]. Lippert TH, Seeger H, Mueck AO. Arzneimittelforschung; 1999 Aug; 49(8):649-62. PubMed ID: 10483510 [Abstract] [Full Text] [Related]
23. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). Adlercreutz H, Höckerstedt K, Bannwart C, Bloigu S, Hämäläinen E, Fotsis T, Ollus A. J Steroid Biochem; 1987 Aug; 27(4-6):1135-44. PubMed ID: 2826899 [Abstract] [Full Text] [Related]
24. Effect of energy deficiency on estrogen metabolism in premenopausal women. Westerlind KC, Williams NI. Med Sci Sports Exerc; 2007 Jul; 39(7):1090-7. PubMed ID: 17596776 [Abstract] [Full Text] [Related]
25. Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells. Seeger H, Wallwiener D, Kraemer E, Mueck AO. Maturitas; 2006 Apr 20; 54(1):72-7. PubMed ID: 16213115 [Abstract] [Full Text] [Related]
27. Urinary hydroxyestrogens and breast cancer risk among postmenopausal women: a prospective study. Wellejus A, Olsen A, Tjonneland A, Thomsen BL, Overvad K, Loft S. Cancer Epidemiol Biomarkers Prev; 2005 Sep 20; 14(9):2137-42. PubMed ID: 16172222 [Abstract] [Full Text] [Related]
28. The effects of an isoflavone intervention on the urinary excretion of hormone metabolites in premenopausal women. Maskarinec G, Franke AA, Williams AE, Stanczyk FC. IARC Sci Publ; 2002 Sep 20; 156():375-7. PubMed ID: 12484210 [No Abstract] [Full Text] [Related]
35. Association of genetic polymorphisms with serum estrogens measured multiple times during a 2-year period in premenopausal women. Lurie G, Maskarinec G, Kaaks R, Stanczyk FZ, Le Marchand L. Cancer Epidemiol Biomarkers Prev; 2005 Jun 09; 14(6):1521-7. PubMed ID: 15941966 [Abstract] [Full Text] [Related]
37. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Muti P, Bradlow HL, Micheli A, Krogh V, Freudenheim JL, Schünemann HJ, Stanulla M, Yang J, Sepkovic DW, Trevisan M, Berrino F. Epidemiology; 2000 Nov 09; 11(6):635-40. PubMed ID: 11055622 [Abstract] [Full Text] [Related]
40. Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics. Dai Q, Franke AA, Yu H, Shu XO, Jin F, Hebert JR, Custer LJ, Gao YT, Zheng W. Cancer Epidemiol Biomarkers Prev; 2003 Jun 09; 12(6):497-502. PubMed ID: 12814993 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]